Skip to Main Content

Author Details

Jaime Ferrer
Health Research Institute Hospital La Fe
1999
30
15
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
34991512Local detection of microvessels in IDH-wildtype glioblastoma using relative cerebral blood volume: an imaging marker useful for astrocytoma grade 4 classification.BMC Cancer2022
35084970Nests of dividing neuroblasts sustain interneuron production for the developing human brain.Science2022
33403231Evaluation of the optical criteria for sessile serrated lesions of the colon: A prospective study on a colorectal cancer screening population.Endosc Int Open2021
33544856Heterogeneous Pattern of Differentiation With BCAS1/NABC1 Expression in a Case of Oligodendroglioma.J Neuropathol Exp Neurol2021
33897583Deciphering Multiple Sclerosis Progression.Front Neurol2021
31932008[Gastric gastrointestinal stromal tumour and schwannoma: An unusual presentation in a patient without neurofibromatosis].Rev Esp Patol2020
26104271Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases.Liver Int2016
27404455Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma.Br J Cancer2016
24414130Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study.Breast Cancer Res Treat2014
25047087MicroRNA profile in very young women with breast cancer.BMC Cancer2014
24608573Concordance of genomic alterations between primary and recurrent breast cancer.Mol Cancer Ther2014
24398047Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer.Clin Cancer Res2014
23809906An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancer.Breast2013
24197449High stability of microRNAs in tissue samples of compromised quality.Virchows Arch2013
21908496Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer.Ann Oncol2012
22584435High ERK protein expression levels correlate with shorter survival in triple-negative breast cancer patients.Oncologist2012
21490305PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer.Mol Cancer Ther2011
21558518A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.JAMA2011
21712485Prognostic impact of phosphorylated HER-2 in HER-2+ primary breast cancer.Oncologist2011
19933078Outcome differences between patients with node-negative breast cancer classified according to the st. Gallen risk categories.Clin Breast Cancer2009
16836516Basal cell carcinoma with distant multiple metastases to the vertebral column.J Eur Acad Dermatol Venereol2006
15517365Anaplastic carcinoma of the thyroid with rhabdomyosarcomatous differentiation: a report of two cases.Virchows Arch2005
12808123Establishment and characterization of a continuous human chondrosarcoma cell line, ch-2879: comparative histologic and genetic studies with its tumor of origin.Lab Invest2003
12850375Cytogenetic and molecular findings related to rhabdomyosarcoma. An analysis of seven cases.Cancer Genet Cytogenet2003
12028654Diffuse type of giant-cell tumor of tendon sheath: an ultrastructural study of two cases with cytogenetic support.Ultrastruct Pathol2002
10698219Clear cell syringoid carcinoma: an ultrastructural and immunohistochemical study.Am J Dermatopathol2000
10802923[Renal cell carcinoma associated with renal angiomyolipoma and renal cortical adenoma].Arch Esp Urol2000
11494000Warty Carcinoma Arising in Condyloma Acuminatum of Urinary Bladder: A Case Report.Int J Surg Pathol2000
10327675[Multiple analysis of morphologic factors with prognostic value in transitional cell papillary carcinoma of the bladder. Retrospective study of 571 cases].Actas Urol Esp1999
10431850Hepatoid adenocarcinoma of the urinary bladder. An unusual neoplasm.Virchows Arch1999
  • 1 - 30 of 30

Recommended Authors

Kentaro Ohara
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 2012
Number of shared co-authors 0
Shaham Beg
New York-Presbyterian Hospital-Weill Cornell Medical College
Career Start Year 2008
Number of shared co-authors 1
Vaibhav Chumbalkar
Moffitt Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Bernadette Liegl-Atzwanger
Diagnostic and Research Institute of Pathology, Medical University of Graz
Career Start Year 2003
Number of shared co-authors 0
Elizabeth G Demicco
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Career Start Year 2000
Number of shared co-authors 1
Abbas Agaimy
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Career Start Year 2000
Number of shared co-authors 0
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 0
Ralf Kemmerling
Institute of Pathology, Paracelsus Medical University
Career Start Year 2000
Number of shared co-authors 0
Paul Fr??neaux
Institut Curie
Career Start Year 1999
Number of shared co-authors 0
Cristina R Antonescu
Memorial Sloan Kettering Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Brendan C Dickson
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Career Start Year 1997
Number of shared co-authors 0
Gonzague de Pinieux
University Hospital of Tours
Career Start Year 1996
Number of shared co-authors 0
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 5
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Career Start Year 1994
Number of shared co-authors 0
Roberto Tirabosco
University College London, UCL Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Jason L Hornick
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1993
Number of shared co-authors 1
Sarah M Dry
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 0
Holger Moch
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 1
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 8
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 5
Pedram Argani
The Johns Hopkins Hospital
Career Start Year 1987
Number of shared co-authors 1
Rex C Bentley
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Cyril Fisher
University Hospitals Birmingham NHS Foundation Trust
Career Start Year 1984
Number of shared co-authors 0
Jos?? Palacios
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 1
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Career Start Year 1983
Number of shared co-authors 3
Jahn M Nesland
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 0
Markku Miettinen
National Cancer Institute
Career Start Year 1980
Number of shared co-authors 0
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 0
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 1
Bogdan Czerniak
University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 3

Collaborators

Gabriel N Hortobagyi
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Co-authored papers 2
Vincent A Miller
Injury Prevention Research Center, University of North Carolina
Co-authored papers 2
Jeffrey S Ross
Foundation Medicine
Co-authored papers 2
Roman Yelensky
Co-authored papers 2
Jos?? Manuel Garc??a-Verdugo
Cavanilles Institute, University of Valencia
Co-authored papers 2
Joan Albanell
Hospital del Mar Research Institute
Co-authored papers 2
Lajos Pusztai
Co-authored papers 2
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2
Abel Gonzalez-Perez
Universitat Pompeu Fabra
Co-authored papers 1
Michael C Oldham
University of California san francisco
Co-authored papers 1
Hui Wang
Co-authored papers 1
Colin Studholme
University of Washington
Co-authored papers 1
Vivian Tang
University of California san francisco
Co-authored papers 1
Eleni Andreopoulou
New York Presbyterian Hospital
Co-authored papers 1
Phillip Larimer
University of California san francisco
Co-authored papers 1
Mercedes F Paredes
University of California san francisco
Co-authored papers 1
Myles Brown
Co-authored papers 1
Quetzal Flores-Ramirez
University of California san francisco
Co-authored papers 1
Massimo Cristofanilli
Weill Cornell School of Medicine
Co-authored papers 1
Julien Spatazza
Neurona Therapeutics Inc.
Co-authored papers 1
Cristina Mora
University of California san francisco
Co-authored papers 1
Ashley Del Dosso
University of California san francisco
Co-authored papers 1
William F Symmans
Co-authored papers 1
Kirsten Obernier (CM4AI)
University of California San Francisco
Co-authored papers 1
Susana Gonzalez Granero
Co-authored papers 1
Eric J Huang
University of California san francisco
Co-authored papers 1
Ossama Tawfik
University of Kansas
Co-authored papers 1
Chen Hu
Johns Hopkins University School of Medicine
Co-authored papers 1
Release 1.2